Susquehanna International Group, LLP Biotechnology

Susquehanna International Group, LLP

  • $688 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
NVO
Novo Nordisk A S
PUT
$400 Million
5.79M
Q2 2025
Reduced 0.58%
REGN
Regeneron Pharmaceuticals, Inc.
PUT
$378 Million
720K
Q2 2025
Added 8.34%
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$289 Million
551K
Q2 2025
Added 8.34%
VRTX
Vertex Pharmaceuticals Inc
CALL
$215 Million
483K
Q2 2025
Added 51.28%
VRTX
Vertex Pharmaceuticals Inc
PUT
$181 Million
406K
Q2 2025
Added 51.28%
MRNA
Moderna, Inc.
PUT
$174 Million
6.31M
Q2 2025
Added 131.88%
NVO
Novo Nordisk A S
CALL
$152 Million
2.21M
Q2 2025
Reduced 0.58%
MRNA
Moderna, Inc.
CALL
$149 Million
5.41M
Q2 2025
Added 131.88%
BBIO
Bridge Bio Pharma, Inc.
CALL
$127 Million
2.94M
Q2 2025
Reduced 14.21%
INSM
Insmed Inc
PUT
$109 Million
1.08M
Q2 2025
Reduced 52.69%
INSM
Insmed Inc
CALL
$101 Million
1M
Q2 2025
Reduced 52.69%
VRNA
Verona Pharma PLC
PUT
$91.6 Million
969K
Q1 2025
Reduced 69.77%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$66.1 Million
203K
Q2 2025
Added 195.55%
BPMC
Blueprint Medicines Corp
PUT
$58.6 Million
457K
Q2 2025
Reduced 55.37%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$56.6 Million
174K
Q2 2025
Added 195.55%
UTHR
United Therapeutics Corp
PUT
$49.5 Million
172K
Q2 2025
Added 250.34%
VKTX
Viking Therapeutics, Inc.
PUT
$48.9 Million
1.85M
Q2 2025
Added 23.25%
VKTX
Viking Therapeutics, Inc.
CALL
$47.6 Million
1.8M
Q2 2025
Added 23.25%
BNTX
Bio N Tech Se
PUT
$42 Million
394K
Q2 2025
Added 32.68%
VRNA
Verona Pharma PLC
CALL
$39.9 Million
421K
Q1 2025
Reduced 69.77%
CRSP
Crispr Therapeutics Ag
CALL
$39.3 Million
807K
Q2 2025
Added 164.57%
MDGL
Madrigal Pharmaceuticals, Inc.
PUT
$36.5 Million
121K
Q2 2025
Reduced 29.67%
BNTX
Bio N Tech Se
CALL
$35.2 Million
331K
Q2 2025
Added 32.68%
ARGX
Argenx Se
CALL
$34.2 Million
62.1K
Q2 2025
Added 1170.15%
SWTX
Spring Works Therapeutics, Inc.
PUT
$34.1 Million
727K
Q2 2025
Reduced 22.25%
AXSM
Axsome Therapeutics, Inc.
PUT
$30.5 Million
292K
Q2 2025
Added 104.97%
UTHR
United Therapeutics Corp
CALL
$30 Million
104K
Q2 2025
Added 250.34%
AKRO
Akero Therapeutics, Inc.
CALL
$28.8 Million
540K
Q2 2025
Added 15.17%
KRYS
Krystal Biotech, Inc.
CALL
$26 Million
189K
Q2 2025
Reduced 10.57%
BBIO
Bridge Bio Pharma, Inc.
PUT
$25.8 Million
597K
Q2 2025
Reduced 14.21%
EXEL
Exelixis, Inc.
CALL
$25.6 Million
582K
Q2 2025
Reduced 60.8%
SRPT
Sarepta Therapeutics, Inc.
CALL
$24.7 Million
1.44M
Q2 2025
Added 206.67%
TGTX
Tg Therapeutics, Inc.
CALL
$24.3 Million
676K
Q2 2025
Added 83.15%
CRSP
Crispr Therapeutics Ag
PUT
$23.9 Million
492K
Q2 2025
Added 164.57%
BMRN
Biomarin Pharmaceutical Inc
CALL
$23.3 Million
423K
Q2 2025
Reduced 82.64%
SMMT
Summit Therapeutics Inc.
CALL
$23 Million
1.08M
Q2 2025
Added 18.33%
TGTX
Tg Therapeutics, Inc.
PUT
$22.5 Million
625K
Q2 2025
Added 83.15%
SMMT
Summit Therapeutics Inc.
PUT
$22.3 Million
1.05M
Q2 2025
Added 18.33%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$22.2 Million
73.4K
Q2 2025
Reduced 29.67%
ACLX
Arcellx, Inc.
PUT
$21.5 Million
327K
Q2 2025
Added 2.13%
ARGX
Argenx Se
PUT
$19.3 Million
35K
Q2 2025
Added 1170.15%
AXSM
Axsome Therapeutics, Inc.
CALL
$18.6 Million
178K
Q2 2025
Added 104.97%
RARE
Ultragenyx Pharmaceutical Inc.
CALL
$18.4 Million
506K
Q2 2025
Reduced 33.4%
EXEL
Exelixis, Inc.
PUT
$17.5 Million
396K
Q2 2025
Reduced 60.8%
AKRO
Akero Therapeutics, Inc.
PUT
$17.4 Million
325K
Q2 2025
Added 15.17%
IONS
Ionis Pharmaceuticals Inc
CALL
$17 Million
431K
Q1 2025
Added 175.52%
ADMA
Adma Biologics, Inc.
CALL
$16.9 Million
931K
Q2 2025
Added 57.28%
RARE
Ultragenyx Pharmaceutical Inc.
PUT
$16.9 Million
464K
Q2 2025
Reduced 33.4%
QURE
Uni Qure N.V.
CALL
$16.8 Million
1.2M
Q2 2025
Added 16.78%
Filter Shares Options
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email